PT Pyridam Farma Tbk (IDX:PYFA)

Market Cap	2.49T -59.6%
Revenue (ttm)	2.99T +3.2%
Net Income	-344.75B
EPS	-29.84
Shares Out	11.24B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,301,200
Open	228.00
Previous Close	226.00
Day's Range	214.00 - 232.00
52-Week Range	158.00 - 665.00
Beta	0.82
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About PT Pyridam Farma Tbk

PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Employees: 2,463
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PYFA

Financial Performance

In 2025, PT Pyridam Farma Tbk's revenue was 2.76 trillion, an increase of 43.71% compared to the previous year's 1.92 trillion. Losses were -379.67 billion, 15.0% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 12, 2026

Data Sources Report a data error